Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life
Corporate - Media & Press - Press Release
Arrayit Corporation and Vivos Team Up on Global Genome Vault
Arrayit Corporation, May 13, 2015, 12:21 PM EDT
SUNNYVALE, CA / ACCESSWIRE / May 13, 2015 / Arrayit Corporation (OTCQB: ARYC) a life science technology leader, announces an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth.
Vivos offers an impervious, impenetrable and permanent DNA storage vault, able to provide virtually every man, woman and child on Earth, a safe and secure, nuclear blast-proof, underground shelter to store their DNA. It is predicted in the near future that your own DNA will be used to extend your life. Healthy DNA will be used as a means of regenerative medicine, to restore normal healthy function to body organs, skin tissue, and parts damaged by disease, injured by trauma, or just worn out by time. Storing a small sample of your DNA as it exists today may assure a longer life through cures and the restoration of virtually every cell in your body. Arrayit blood cards allow the rapid collection, separation, drying and storage of human genomic DNA in a format that is permanent and highly miniaturized.
Arrayit CEO Rene Schena states, "We are pleased to partner with Vivos on this ambitious scientific project. Rapid advances in biomedical research offer the promise of future scientific breakthroughs based on high quality archival genomic DNA." Vivos CEO and founder Robert Vicino adds, "Arrayit technology will play an instrumental role in safely and confidentially storing private customer DNA samples in the Global Genome Vault. Preserving your DNA for posterity provides the personal blueprint required to leverage scientific advances including possible medical regeneration and life extension in the future."
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. Please visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2014.
Copyright 1993-2019 Arrayit Corporation. All rights reserved.